Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Amantadine hydrochloride
Drug ID BADD_D00098
Description An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.
Indications and Usage For the chemoprophylaxis, prophylaxis, and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Also for the treatment of parkinsonism and drug-induced extrapyramidal reactions.
Marketing Status approved
ATC Code N04BB01
DrugBank ID DB00915
KEGG ID D00777
MeSH ID D000547
PubChem ID 64150
TTD Drug ID D08MCS
NDC Product Code 43744-026; 10135-693; 0121-0646; 42799-118; 55154-9444; 71335-0469; 42806-716; 50268-069; 70859-012; 16571-834; 17856-0646; 62135-010; 69452-142; 0591-4920; 0615-8263; 0832-0111; 10888-8149; 0904-7042; 17373-1446; 38779-0411; 63818-0435; 42543-493; 71335-9618; 10135-692; 72888-033; 73152-076; 61474-4269; 62135-609; 64380-862; 71205-223; 49452-0395; 62991-2559; 65841-835; 68382-512; 70518-3381; 10695-014; 42543-497; 71205-702; 0832-1015; 52932-0707; 23155-362; 24689-112; 42291-125; 50383-807; 69097-925; 69097-926; 51927-1754; 24689-105; 53002-3750
UNII M6Q1EO9TD0
Synonyms Amantadine | 1-Aminoadamantane | 1 Aminoadamantane | Adamantylamine | Wiregyt | Amanta | Amanta-HCI-AZU | Amanta HCI AZU | AmantaHCIAZU | Amanta-Sulfate-AZU | Amanta Sulfate AZU | AmantaSulfateAZU | Amantadin AZU | AZU, Amantadin | Amantadin AL | AL, Amantadin | Amantadin Stada | Stada, Amantadin | Amantadin-neuraxpharm | Amantadin neuraxpharm | Amantadinneuraxpharm | Amantadin-ratiopharm | Amantadin ratiopharm | Amantadinratiopharm | Amantadina Juventus | Juventus, Amantadina | Amantadina Llorente | Llorente, Amantadina | Amantadine Hydrochloride | Hydrochloride, Amantadine | Amantadine Sulfate | Sulfate, Amantadine | Amixx | Cerebramed | Gen-Amantadine | Gen Amantadine | GenAmantadine | Infecto-Flu | Infecto Flu | InfectoFlu | Infex | Midantan | PMS-Amantadine | PMS Amantadine | PMSAmantadine | Symadine | Symmetrel | Endantadine | Mantadix | tregor | Viregyt | Adekin | Aman
Chemical Information
Molecular Formula C10H18ClN
CAS Registry Number 665-66-7
SMILES C1C2CC3CC1CC(C2)(C3)N.Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Nausea07.01.07.001--
Nervousness19.06.02.003---
Neuroleptic malignant syndrome08.05.01.005; 12.03.01.003; 15.05.04.015; 17.05.02.003---
Neutropenia01.02.03.004---
Oculogyric crisis06.05.02.002; 17.01.03.002---
Oedema08.01.07.006; 14.05.06.010---
Oedema peripheral02.05.04.007; 08.01.07.007; 14.05.06.011--
Orthostatic hypotension17.05.01.020; 24.06.03.004---
Paraesthesia17.02.06.005; 23.03.03.094--
Paranoia19.05.01.005---
Photophobia06.01.01.004; 17.17.02.006--
Pruritus23.03.12.001--
Pulmonary oedema02.05.02.003; 22.01.03.003--
Pyrexia08.05.02.003--
Rash23.03.13.001---
Seizure17.12.03.001--
Somnolence17.02.04.006; 19.02.05.003--
Stupor17.02.04.007; 19.02.05.004---
Suicidal ideation19.12.01.003--
Tachycardia02.03.02.007---
Tachypnoea22.02.01.014---
Thinking abnormal17.02.05.023; 19.10.03.001---
Tremor17.01.06.002--
Urinary retention20.02.02.011--
Ventricular arrhythmia02.03.04.006--
Visual acuity reduced06.02.10.012; 17.17.01.011--
Visual impairment06.02.10.013---
Vomiting07.01.07.003--
Self-injurious ideation19.12.01.007---
Blood alkaline phosphatase increased13.04.02.004--
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages